» Articles » PMID: 28126025

Anti-inflammatory Properties of Amniotic Membrane Patch Following Pericardiectomy for Constrictive Pericarditis

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Since constrictive pericarditis is most often idiopathic and the pathophysiology remains largely unknown, both the diagnosis and the treatment can be challenging. However, by definition, inflammatory processes are central to this disease process. Amniotic membrane patches have been shown to possess anti-inflammatory properties and are believed to be immune privileged. Due to these properties, amniotic membrane patches were applied intraoperatively in a complicated patient presenting with constrictive pericarditis.

Case Presentation: A patient with a history of multiple cardiac surgeries presented with marked fatigue, worsening dyspnea and sinus tachycardia. He was found to have constrictive physiology during cardiac catheterization, with cardiac MRI demonstrating hepatic vein dilatation, atrial enlargement and ventricular narrowing. After amniotic membrane patch treatment and pericardiectomy, post-operative cardiac MRI failed to demonstrate any appreciable pericardial effusion or inflammation, with no increased T2 signal that would suggest edema.

Conclusions: Given the positive results seen in this complex patient, we suggest continued research into the beneficial properties of amniotic membrane patches in cardiac surgery.

Citing Articles

Development of a sterilization process for amniotic membrane allograft tissue using supercritical carbon dioxide and NovaKill.

OConnell J, Pentakota K, Villeareal D, Faz J, Li X, Trinh A Cell Tissue Bank. 2024; 26(1):4.

PMID: 39680266 PMC: 11649788. DOI: 10.1007/s10561-024-10152-1.


A randomized, double-blinded, placebo-controlled clinical trial of sterile filtered human amniotic fluid for treatment of COVID-19.

Tonna J, Pierce J, Brintz B, Bardsley T, Hatton N, Lewis G BMC Infect Dis. 2023; 23(1):864.

PMID: 38066442 PMC: 10704623. DOI: 10.1186/s12879-023-08856-y.


Comparison of the Efficacy of Amniotic Membrane Versus Buccal Fat Pad in Treatment of Oral Submucous Fibrosis.

Sharma S, Mehra H, Gupta H, Agarwal R, Gangwar A, Kumar A J Maxillofac Oral Surg. 2023; 22(3):525-532.

PMID: 37534347 PMC: 10390447. DOI: 10.1007/s12663-022-01709-2.


Chick early amniotic fluid component improves heart function and protects against inflammation after myocardial infarction in mice.

Wang J, Chen X, Zhang L, Zheng Y, Qian J, Sun N Front Cardiovasc Med. 2022; 9:1042852.

PMID: 36465449 PMC: 9710540. DOI: 10.3389/fcvm.2022.1042852.


Strategies for immortalisation of amnion-derived mesenchymal and epithelial cells.

Ansari A, Denton K, Lim R Cell Biol Int. 2022; 46(12):1999-2008.

PMID: 35998259 DOI: 10.1002/cbin.11892.


References
1.
Khalpey Z, Marsh K, Ferng A, Riaz I, Friedman M, Indik J . First in man: amniotic patch reduces postoperative inflammation. Am J Med. 2014; 128(1):e5-6. DOI: 10.1016/j.amjmed.2014.08.028. View

2.
Cargnoni A, Di Marcello M, Campagnol M, Nassuato C, Albertini A, Parolini O . Amniotic membrane patching promotes ischemic rat heart repair. Cell Transplant. 2009; 18(10):1147-59. DOI: 10.3727/096368909X12483162196764. View

3.
Little W, Freeman G . Pericardial disease. Circulation. 2006; 113(12):1622-32. DOI: 10.1161/CIRCULATIONAHA.105.561514. View

4.
Hemphill C, Stavoe K, Khalpey Z . First in man: amniotic stem cell injection promotes scar remodeling and healing processes in late-stage fibrosis. Int J Cardiol. 2014; 174(2):442-3. DOI: 10.1016/j.ijcard.2014.04.023. View

5.
Kim H, Choi O . Neovascularization in a mouse model via stem cells derived from human fetal amniotic membranes. Heart Vessels. 2010; 26(2):196-205. DOI: 10.1007/s00380-010-0064-6. View